- Report
- March 2024
- 185 Pages
Global
From €3244EUR$3,374USD£2,783GBP
€3605EUR$3,749USD£3,092GBP
- Report
- September 2023
- 170 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- February 2024
- 200 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- November 2023
- 145 Pages
Global
From €2403EUR$2,499USD£2,061GBP
- Report
- February 2024
- 180 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- January 2024
- 140 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- December 2023
- 275 Pages
Global
€4803EUR$4,995USD£4,120GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1442EUR$1,500USD£1,237GBP
- Report
- January 2023
- 150 Pages
United States
From €3798EUR$3,950USD£3,258GBP
- Report
- January 2022
- 200 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- April 2023
- 120 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- January 2022
- 60 Pages
Global
From €3798EUR$3,950USD£3,258GBP
- Report
- August 2022
- 120 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- April 2021
- 120 Pages
Global
From €2404EUR$2,500USD£2,062GBP
- Report
- August 2022
United States
From €1865EUR$1,940USD£1,600GBP
- Report
- August 2022
Global
From €760EUR$790USD£652GBP
- Report
- August 2021
Global
From €3837EUR$3,990USD£3,291GBP
- Report
- August 2021
Europe
From €3288EUR$3,420USD£2,821GBP
- Report
- February 2021
Global
From €2846EUR$2,960USD£2,442GBP
- Clinical Trials
- September 2020
- 227 Pages
Global
From €2404EUR$2,500USD£2,062GBP
Actinic Keratosis (AK) is a pre-cancerous skin condition caused by long-term exposure to ultraviolet (UV) radiation. It is characterized by scaly, rough patches on the skin that can become cancerous if left untreated. Skin cancer drugs are used to treat AK and prevent it from progressing to a more serious form of skin cancer. These drugs are typically topical creams or ointments that are applied directly to the affected area. They work by slowing down the growth of abnormal cells and preventing them from spreading.
The Actinic Keratosis Drug market is a subset of the larger Skin Cancer Drug market. It is composed of a variety of products, including topical creams, ointments, and other treatments. These products are used to treat AK and prevent it from progressing to a more serious form of skin cancer.
Some companies in the Actinic Keratosis Drug market include Galderma, Leo Pharma, and Sun Pharmaceuticals. Show Less Read more